Skip to main content

Table 2 Univariate and multivariate analysis of gastric cancer patients’ clinicopathological features for survival

From: Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection

Characteristics

5-YSR (%)

Univariate

P value*

HR

Multivariate

P value

Sex

 

0.000

 

0.951

Male

68.2

 

Ref

 

Female

0

 

408620.765

 

Age

 

0.624

  

 <60

41.7

   

 ≥60

65.5

   

Differentiation

 

0.034

 

0.191

 Differentiated

85.7

 

Ref

4.685

 

 Undifferentiated

25.7

  

Primary tumor size

 

0.853

  

 <3 cm

66.7

   

 ≥3 cm

58.1

   

Lymphatic invasion

 

0.822

  

 LI (−)

66.7

   

 LI (+)

60.2

   

Vascular invasion

 

0.369

  

 VI (−)

58.2

   

 VI (+)

50.0

   

Perineural invasion

 

0.959

  

 PI (−)

67.5

   

 PI (+)

55.6

   

T stage

 

0.266

  

 T1-2

40.0

   

 T3-4

73.3

   

N stage

 

0.448

  

 N0

50.0

   

 N1-3

62.2

   

AJCC 7th stage

 

0.779

  

 Stage 1–2

66.7

   

 Stage 3-4

56.3

   

Number of metastatic

Tumor

 

0.237

  

 Single

58.6

   

 Multiple

66.7

   

Size of metastatic

Tumor

 

0.427

  

 <3 cm

64.8

   

 ≥3 cm

58.3

   

Lobar distribution

 

0.821

  

 Unilobar

66.8

   

 Bilobar

50.0

   

Type of treatment

 

0.671

  

 Hepatic resection

68.6

   

 RFA

47.6

   
  1. 5-YSR 5-year survival rate, HR hazard ratio, LI lymphatic invasion, VI venous invasion, NI perineural invasion, RFA radiofrequency ablation
  2. *log-rank test
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us